{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:23:17Z","timestamp":1789741397751,"version":"4.0.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Program of National Natural Science Foundation","award":["81590766"],"award-info":[{"award-number":["81590766"]}]},{"name":"National Major Program Project Grant on Biosafety","award":["2016YFC1201000"],"award-info":[{"award-number":["2016YFC1201000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302702"],"award-info":[{"award-number":["81302702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova program","doi-asserted-by":"publisher","award":["xxjh2015A052"],"award-info":[{"award-number":["xxjh2015A052"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC1200400"],"award-info":[{"award-number":["2016YFC1200400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barr\u00e9 syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Food and Drug Admistration-approved drug that is safe for pediatric use. Nitazoxanide and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and we identified that they exerts antiviral effect possibly by targeting the viral postattachment step.<\/jats:p>","DOI":"10.1093\/ofid\/ofx009","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T18:04:15Z","timestamp":1486145055000},"source":"Crossref","is-referenced-by-count":40,"title":["Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika"],"prefix":"10.1093","volume":"4","author":[{"given":"Rui-Yuan","family":"Cao","sequence":"first","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-fen","family":"Xu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Hao","sequence":"additional","affiliation":[{"name":"Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Chinese Academy of Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhong","sequence":"additional","affiliation":[{"name":"Beijing Institute of Pharmacology and Toxicology, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"2020081005071391100_CIT0001","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.14.20761","article-title":"Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014","volume":"19","author":"Musso","year":"2014","journal-title":"Euro Surveill"},{"key":"2020081005071391100_CIT0002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(16)30083-4","article-title":"Clinical management of pregnant women exposed to Zika virus","volume":"16","author":"Vouga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2020081005071391100_CIT0003","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(16)00742-X","article-title":"Microcephaly and Zika virus infection","volume":"387","author":"Rodrigues","year":"2016","journal-title":"Lancet"},{"key":"2020081005071391100_CIT0004","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(16)00644-9","article-title":"Acute myelitis due to Zika virus infection","volume":"387","author":"M\u00e9charles","year":"2016","journal-title":"Lancet"},{"key":"2020081005071391100_CIT0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature20556","article-title":"Zika virus infection damages the testes in mice","volume":"540","author":"Govero","year":"2016","journal-title":"Nature"},{"key":"2020081005071391100_CIT0006","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"key":"2020081005071391100_CIT0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2020081005071391100_CIT0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J Infect Dis"},{"key":"2020081005071391100_CIT0009","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res"},{"key":"2020081005071391100_CIT0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jvh.12446","article-title":"Aspirin inhibits hepatitis C virus entry by downregulating claudin-1","volume":"23","author":"Yin","year":"2016","journal-title":"J Viral Hepat"},{"key":"2020081005071391100_CIT0011","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M115.657346","article-title":"The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry","volume":"290","author":"Narayana","year":"2015","journal-title":"J Biol Chem"},{"key":"2020081005071391100_CIT0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"Korba","year":"2008","journal-title":"Antiviral Res"},{"key":"2020081005071391100_CIT0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2014.05.015","article-title":"Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores","volume":"462-463","author":"Ashiru","year":"2014","journal-title":"Virology"},{"key":"2020081005071391100_CIT0014","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J Biol Chem"},{"key":"2020081005071391100_CIT0015"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/1\/ofx009\/33622629\/ofx009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/1\/ofx009\/33622629\/ofx009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T05:07:58Z","timestamp":1597036078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofx009\/2967820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofx009","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017]]},"published":{"date-parts":[[2017,1,1]]},"article-number":"ofx009"}}